Immune Complex Mediated Glomerulonephritis with Acute Thrombotic Microangiopathy following Newly Detected Hepatitis B Virus Infection in a Kidney Transplant Recipient

Hepatitis B virus (HBV) presents a risk to patients and staff in renal units. To minimise viral transmission, there are international and UK guidelines recommending HBV immunisation for patients commencing renal replacement therapy (RRT) and HBV surveillance in kidney transplant recipients. We repor...

Full description

Saved in:
Bibliographic Details
Main Authors: Tracey Salter, Hannah Burton, Sam Douthwaite, William Newsholme, Catherine Horsfield, Rachel Hilton
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Transplantation
Online Access:http://dx.doi.org/10.1155/2016/3152495
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849693350467207168
author Tracey Salter
Hannah Burton
Sam Douthwaite
William Newsholme
Catherine Horsfield
Rachel Hilton
author_facet Tracey Salter
Hannah Burton
Sam Douthwaite
William Newsholme
Catherine Horsfield
Rachel Hilton
author_sort Tracey Salter
collection DOAJ
description Hepatitis B virus (HBV) presents a risk to patients and staff in renal units. To minimise viral transmission, there are international and UK guidelines recommending HBV immunisation for patients commencing renal replacement therapy (RRT) and HBV surveillance in kidney transplant recipients. We report the case of a 56-year-old male who was immunised against HBV before starting haemodialysis. He received a deceased donor kidney transplant three years later, at which time there was no evidence of HBV infection. After a further six years he developed an acute kidney injury; allograft biopsy revealed an acute thrombotic microangiopathy (TMA) with glomerulitis, peritubular capillaritis, and C4d staining. Due to a “full house” immunoprofile, tests including virological screening were undertaken, which revealed acute HBV infection. Entecavir treatment resulted in an improvement in viral load and kidney function. HBV genotyping demonstrated a vaccine escape mutant, suggesting “past resolved” infection that reactivated with immunosuppression, though posttransplant acquisition cannot be excluded. This is the first reported case of acute HBV infection associated with immune complex mediated glomerulonephritis and TMA. Furthermore, it highlights the importance of HBV surveillance in kidney transplant recipients, which although addressed by UK guidelines is not currently practiced in all UK units.
format Article
id doaj-art-329e8fd3ab2a4bdca26929620bea24e3
institution DOAJ
issn 2090-6943
2090-6951
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Transplantation
spelling doaj-art-329e8fd3ab2a4bdca26929620bea24e32025-08-20T03:20:27ZengWileyCase Reports in Transplantation2090-69432090-69512016-01-01201610.1155/2016/31524953152495Immune Complex Mediated Glomerulonephritis with Acute Thrombotic Microangiopathy following Newly Detected Hepatitis B Virus Infection in a Kidney Transplant RecipientTracey Salter0Hannah Burton1Sam Douthwaite2William Newsholme3Catherine Horsfield4Rachel Hilton5Departments of Nephrology and Transplantation, Guy’s and St Thomas’ NHS Foundation Trust, London, UKDepartments of Nephrology and Transplantation, Guy’s and St Thomas’ NHS Foundation Trust, London, UKDepartment of Virology, Guy’s and St Thomas’ NHS Foundation Trust, London, UKDepartment of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UKDepartment of Histopathology, Guy’s and St Thomas’ NHS Foundation Trust, London, UKDepartments of Nephrology and Transplantation, Guy’s and St Thomas’ NHS Foundation Trust, London, UKHepatitis B virus (HBV) presents a risk to patients and staff in renal units. To minimise viral transmission, there are international and UK guidelines recommending HBV immunisation for patients commencing renal replacement therapy (RRT) and HBV surveillance in kidney transplant recipients. We report the case of a 56-year-old male who was immunised against HBV before starting haemodialysis. He received a deceased donor kidney transplant three years later, at which time there was no evidence of HBV infection. After a further six years he developed an acute kidney injury; allograft biopsy revealed an acute thrombotic microangiopathy (TMA) with glomerulitis, peritubular capillaritis, and C4d staining. Due to a “full house” immunoprofile, tests including virological screening were undertaken, which revealed acute HBV infection. Entecavir treatment resulted in an improvement in viral load and kidney function. HBV genotyping demonstrated a vaccine escape mutant, suggesting “past resolved” infection that reactivated with immunosuppression, though posttransplant acquisition cannot be excluded. This is the first reported case of acute HBV infection associated with immune complex mediated glomerulonephritis and TMA. Furthermore, it highlights the importance of HBV surveillance in kidney transplant recipients, which although addressed by UK guidelines is not currently practiced in all UK units.http://dx.doi.org/10.1155/2016/3152495
spellingShingle Tracey Salter
Hannah Burton
Sam Douthwaite
William Newsholme
Catherine Horsfield
Rachel Hilton
Immune Complex Mediated Glomerulonephritis with Acute Thrombotic Microangiopathy following Newly Detected Hepatitis B Virus Infection in a Kidney Transplant Recipient
Case Reports in Transplantation
title Immune Complex Mediated Glomerulonephritis with Acute Thrombotic Microangiopathy following Newly Detected Hepatitis B Virus Infection in a Kidney Transplant Recipient
title_full Immune Complex Mediated Glomerulonephritis with Acute Thrombotic Microangiopathy following Newly Detected Hepatitis B Virus Infection in a Kidney Transplant Recipient
title_fullStr Immune Complex Mediated Glomerulonephritis with Acute Thrombotic Microangiopathy following Newly Detected Hepatitis B Virus Infection in a Kidney Transplant Recipient
title_full_unstemmed Immune Complex Mediated Glomerulonephritis with Acute Thrombotic Microangiopathy following Newly Detected Hepatitis B Virus Infection in a Kidney Transplant Recipient
title_short Immune Complex Mediated Glomerulonephritis with Acute Thrombotic Microangiopathy following Newly Detected Hepatitis B Virus Infection in a Kidney Transplant Recipient
title_sort immune complex mediated glomerulonephritis with acute thrombotic microangiopathy following newly detected hepatitis b virus infection in a kidney transplant recipient
url http://dx.doi.org/10.1155/2016/3152495
work_keys_str_mv AT traceysalter immunecomplexmediatedglomerulonephritiswithacutethromboticmicroangiopathyfollowingnewlydetectedhepatitisbvirusinfectioninakidneytransplantrecipient
AT hannahburton immunecomplexmediatedglomerulonephritiswithacutethromboticmicroangiopathyfollowingnewlydetectedhepatitisbvirusinfectioninakidneytransplantrecipient
AT samdouthwaite immunecomplexmediatedglomerulonephritiswithacutethromboticmicroangiopathyfollowingnewlydetectedhepatitisbvirusinfectioninakidneytransplantrecipient
AT williamnewsholme immunecomplexmediatedglomerulonephritiswithacutethromboticmicroangiopathyfollowingnewlydetectedhepatitisbvirusinfectioninakidneytransplantrecipient
AT catherinehorsfield immunecomplexmediatedglomerulonephritiswithacutethromboticmicroangiopathyfollowingnewlydetectedhepatitisbvirusinfectioninakidneytransplantrecipient
AT rachelhilton immunecomplexmediatedglomerulonephritiswithacutethromboticmicroangiopathyfollowingnewlydetectedhepatitisbvirusinfectioninakidneytransplantrecipient